You have 9 free searches left this month | for more free features.

untreated hairy cell leukemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hairy Cell Leukemia, Leukemia, Leukemia, Hairy Cell Trial in United States (Vemurafenib, Obinutuzumab)

Active, not recruiting
  • Hairy Cell Leukemia
  • +2 more
  • New Haven, Connecticut
  • +8 more
Feb 7, 2022

Hairy Cell Leukemia Patients

Not yet recruiting
  • Hairy Cell Leukemia
    • (no location specified)
    May 5, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    Hairy Cell Leukemia Trial in La Jolla (Low dose vemurafenib plus rituximab)

    Recruiting
    • Hairy Cell Leukemia
    • Low dose vemurafenib plus rituximab
    • La Jolla, California
      Scripps MD Anderson Cancer Center
    May 19, 2022

    Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

    Recruiting
    • Hairy Cell Leukemia
    • Hairy Cell Leukemia Variant
    • CD22CART cell infusion
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)

    Active, not recruiting
    • Hairy Cell Leukemia
    • Moxetumomab Pasudotox-tdfk
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +71 more
    • Chicago, Illinois
    • +5 more
    Oct 8, 2021

    Hairy Cell and Other Leukemias, and to Develop Recombinant

    Recruiting
    • Hairy Cell Leukemia (HCL)
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

      Active, not recruiting
      • Hairy Cell Leukemia
      • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 13, 2022

      Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

      Terminated
      • Adult Grade III Lymphomatoid Granulomatosis
      • +116 more
      • brentuximab vedotin
      • +2 more
      • Chicago, Illinois
      • +2 more
      Aug 30, 2021

      Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma

      Completed
      • Adult Grade III Lymphomatoid Granulomatosis
      • +88 more
      • Detroit, Michigan
        Barbara Ann Karmanos Cancer Institute
      Apr 14, 2021

      Relapsed/Refractory Waldenstrom Macroglobulinemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Burkitt

      Not yet recruiting
      • Relapsed/Refractory Waldenstrom Macroglobulinemia
      • +3 more
      • Brexucabtagene Autoleucel
      • +2 more
      • (no location specified)
      Sep 8, 2022

      Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

      Not yet recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Small Lymphocytic Lymphoma
      • (no location specified)
      Jul 19, 2023

      Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • (no location specified)
      Jul 10, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • +3 more
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Dec 19, 2022

      Patients Previously Treated WithMustang Bio CAR-T Cell

      Enrolling by invitation
      • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
      • +10 more
      • Prior MB-102 CAR-T cell investigational product.
      • Prior MB-106 CAR-T cell investigational product.
      • Duarte, California
      • +4 more
      Dec 8, 2022

      Moxetumomab Pasudotox-tdfk (LUMOXITI)

      Recruiting
      • Hairy Cell Leukemia
        • Pueblo, Colorado
        • +1 more
        Aug 17, 2022

        Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

        Not yet recruiting
        • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
          • (no location specified)
          Dec 16, 2022

          Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

          Not yet recruiting
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Leukemia
          • (no location specified)
          Nov 30, 2022

          CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

          Not yet recruiting
          • CLL
          • (no location specified)
          Oct 3, 2023

          Hairy Cell Leukemia Patient Data Registry

          Recruiting
          • Leukemia, Other
            • Columbus, Ohio
              Ohio State University Comprehensive Cancer Center
            Apr 1, 2021

            Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

            Recruiting
            • Recurrent Acute Leukemia
            • +16 more
            • Duarte, California
              City of Hope Medical Center
            Nov 22, 2022

            Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) Trial run by the National Heart, Lung, and Blood Institute

            Active, not recruiting
            • Small Lymphocytic Lymphoma
            • CLL (Chronic Lymphocytic Leukemia)
            • Fludarabine Phosphate
            • +2 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Oct 13, 2022

            Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

            Recruiting
            • Leukemia, Acute Myeloid
            • +7 more
            • Denver, Colorado
            • +4 more
            Aug 29, 2022

            Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

            Active, not recruiting
            • Chronic Lymphocytic Leukemia
            • Small Lymphocytic Lymphoma
            • High Dose Methylprednisolone (HDMP)
            • +2 more
            • Tampa, Florida
              H. Lee Moffitt Cancer Center and Research Institute
            Jan 12, 2023